-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PBF-1650 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PBF-1650 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: PBF-1650 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMG-0103 in Low Back Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMG-0103 in Low Back Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AMG-0103 in Low Back Pain Drug Details: AMG-0103 (NF-kB decoy oligodeoxynucleotide)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Edoxaban Tosylate in Atrial Fibrillation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Edoxaban Tosylate in Atrial Fibrillation report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Edoxaban Tosylate in Atrial Fibrillation Drug Details: Edoxaban tosylate (Lixiana,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AD-113 in Obstructive Sleep Apnea
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AD-113 in Obstructive Sleep Apnea report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AD-113 in Obstructive Sleep Apnea Drug Details: AD-113 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – mRNA-1010 in Influenzavirus B Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - mRNA-1010 in Influenzavirus B Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. mRNA-1010 in Influenzavirus B Infections Drug Details: mRNA-1010 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABBV-637 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABBV-637 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ABBV-637 in Colorectal Cancer Drug Details:ABBV-637 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GNR-051 in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GNR-051 in Metastatic Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GNR-051 in Metastatic Melanoma Drug Details:GNR-051 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ARQ-154 in Psoriasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ARQ-154 in Psoriasis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ARQ-154 in Psoriasis Drug Details:ARQ-154 is under development for the treatment of seborrheic dermatitis, scalp...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INNA-051 in Influenza A Virus, H1N1 Subtype Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.INNA-051 in Influenza A Virus, H1N1 Subtype Infections Drug Details: INNA-051 (INNA-X) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabozantinib s-malate in Small-Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabozantinib s-malate in Small-Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabozantinib s-malate in Small-Cell Lung Cancer Drug Details: Cabozantinib s-malate...